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Diabetes is associated with the death and dysfunction of insulin-producing pancreatic b-cells. In other systems, Musashi
genes regulate cell fate via Notch signaling, which we recently showed regulates b-cell survival. Here we show for the ﬁrst time
that human and mouse adult islet cells express mRNA and protein of both Musashi isoforms, as well Numb/Notch/Hes/
neurogenin-3 pathway components. Musashi expression was observed in insulin/glucagon double-positive cells during human
fetal development and increased during directed differentiation of human embryonic stem cells (hESCs) to the pancreatic
lineage.De-differentiationofb-cellswithactivinAincreasedMsi1expression.Endoplasmicreticulum(ER)stressincreasedMsi2
and Hes1, while it decreased Ins1 and Ins2 expression, revealing a molecular link between ER stress and b-cell dedifferentiation
in type 2 diabetes. These effects were independent of changes in Numb protein levels and Notch activation. Overexpression of
MSI1 was sufﬁcient to increase Hes1, stimulate proliferation, inhibit apoptosis and reduce insulin expression, whereas Msi1
knockdown had the converse effects on proliferation and insulin expression. Overexpression of MSI2 resulted in a decrease in
MSI1 expression. Taken together, these results demonstrate overlapping, but distinct roles for Musashi-1 and Musashi-2 in the
control of insulin expression and b-cell proliferation. Our data also suggest that Musashi is a novel link between ER stress and
the compensatory b-cell proliferation and the loss of b-cell gene expression seen in speciﬁc phases of the progression to
type 2 diabetes.
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The destruction and dysfunction of pancreatic insulin-produ-
cing b-cells are hallmarks of diabetes, but the molecular links
between the stresses that cause b-cell death and pathways
that control b-cell function and differentiation are unclear.
Although once thought to be quiescent and terminally
differentiated, we and others have shown that individual adult
pancreatic cells exhibit a dynamic range in differentiation
status.
1–3 Indeed, accumulating evidence reveals striking
plasticitybetweenpancreaticcelltypesandtheisletendocrine
lineages,
4,5 but the effects of cellular stress on plasticity
pathways remain unknown.
Notch and neurogenin-3 (Ngn3) have established roles in
pancreas development.
6 Ngn3 is essential for the develop-
ment of all pancreatic endocrine lineages.
6 During embryonic
development, Notch negatively regulates Ngn3 via its target
gene Hes1.
7 Thus, the Notch signaling pathway is critical at
maintaining a proliferating pool of endocrine progenitor cells
and inﬂuences the timely cell lineage speciﬁcation of exocrine
and endocrine cell differentiation.
8 Accumulating evidence
suggests that these developmental gene networks also have
roles in the adult. We have demonstrated that Ngn3 mRNA
and protein are present in adult human and mouse islets.
9
Inhibiting Notch signaling with N-[(3,5-diﬂuorophenyl)acetyl]-
L-alanyl-2-phenyl]glycine-1,1-dimethylethyl ester (DAPT)
increased Ngn3 levels and induced apoptosis, suggesting
an important role for this pathway in adult b-cell survival.
9
Subsequently, it wasshown thatconditionalknockout ofNgn3
in adult islets impaired b-cell function.
10 Unfortunately, little is
known about the factors that regulate Notch and Ngn3
signaling in the adult pancreatic b-cell.
In other tissues, the RNA-binding protein Musashi, a
translational repressor of Numb,
11 regulates cell fate via
Notch signaling by maintaining a pool of self-renewing stem
cells.
12,13 Targeted disruption of Musashi-1 (Msi1) and
Musashi-2 (Msi2) revealed their roles in maintaining neural
stem cell populations in the adult central nervous system.
14
Expression of Msi1 and Hes1 was also reported in the
stem cell niche of highly proliferative intestinal crypt cells.
15
The Musashi target Numb plays a role in determining cell fate
during embryonic development in some tissues
16 and can
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17 To date,
there are no reports regarding Musashi expression in
developing or mature b-cells or its possible mechanistic roles.
We hypothesized that Musashi expression remains in a
subset of adult b-cells and that it regulates cell fate decisions
in response to cellular stress.
Here,weshowthatbothMusashiisoformsareexpressedin
developing and adult human and mouse islets and b-cells at
the transcript and protein levels. Musashi was more abundant
in dedifferentiated and immature b-cells. Conditions asso-
ciated with type 2 diabetes, such as endoplasmic reticulum
(ER) stress induced by sarco-endoplasmic reticulum Ca
2þ
ATPase inhibition (ER Ca
2þ depletion) or palmitate treat-
ment, increased the expression of the Musashi genes.
Overexpression of MSI1 in mouse insulinoma cell line 6
(MIN6) b-cells increased Hes1 gene expression, increased
proliferation and downregulated insulin gene expression,
whereas knockdown had the opposite effects. Our data
suggest that Musashi genes regulate insulin expression,
apoptosis and proliferation in response to ER stress via Hes1,
but independently of the Numb/Notch pathway.
Results
Musashi is expressed in adult pancreatic islet cells. The
expression and function of Notch pathway components in
adult islets was recently demonstrated,
9,10 but the upstream
regulators of Notch are unclear in these cells. Our iden-
tiﬁcation of MSI1 via mass spectroscopy in a proteomics
study of human islets provided the impetus to investigate
this translational repressor protein. Published gene expres-
sion databases, Tag-Seq libraries and microarray data
sets of ﬂuorescence-activated cell sorting (FACS)-puriﬁed
b-cells
18,19 pointed to the presence of both Musashi
homologs in adult islets and puriﬁed b-cells from humans,
mice and rats, as well as Numb/Numb-like, Notch1-4, Hes1
and Ngn3 (Figure 1a). However, the functional relationships
between the components of this classical Notch pathway
remain understudied in adult b-cells.
We next examined the expression of Msi1 and Msi2 at the
mRNA and protein levels in samples of human and mouse
islets. Reverse transcriptase-polymerase chain reaction
(RT-PCR) analysis showed that both homologs of Musashi
were expressed in adult human and mouse islets (Figures 1b
and c). Reverse transcriptase-quantitative polymerase chain
reaction (RT-qPCR) showed that the expression level of
Msi2 was several fold higher compared with Msi1 in mouse
islets (Figure 1d), consistent with the results obtained from
gene expression databases (Figure 1a). The levels of Msi1
and Msi2 in the islets were similar to those found in the
mouse pituitary (Figure 1d). Immunoﬂuorescence staining
conﬁrmed the presence of MSI1 and MSI2 in a subset of
human glucagon-positive a-cells and insulin-positive b-cells
(Figures 1e and f). MSI1 was found in 61.9±30.1%
of b-cells, while 72.5±3.3% of b-cells were positive for
MSI2. Similarly, the percentages of MSI1- and MSI2-positive
a-cells were 76.2±21.1% and 85.3±0.04%, respectively.
Similar observations were made in mouse a- and b-cells
(Figures 1g and h). We examined the subcellular location
of endogenous Msi1 and Msi2 in MIN6 cells using deconvolu-
tion microscopy and found a punctate cytoplasmic localiza-
tion consistent with a regulation of translation (Figure 1i).
Interestingly, Msi1 protein levels increased with age in adult
mice (Figure 1j), pointing to the possibility that stress
associated with normal aging can upregulate Musashi levels.
Overall, these results conﬁrm the expression of Musashi
genes at the mRNA and protein levels in adult human and
mouse islets and b-cells, as well as in b-cell lines.
Musashi expression dynamics in human development
and hESC differentiation. As Musashi has been proposed
as a stem cell or progenitor cell marker regulating cell fate
during differentiation,
20 we probed for its expression in
human fetal pancreas and during directed differentiation of
human embryonic stem cells (hESCs) towards the pancreatic
lineage (Figures 2 and 3). Both MSI1 and MSI2 proteins were
present in developing human fetal pancreas at 8 weeks,
co-staining with insulin (MSI1, 44.9%; MSI2, 56.1%) and
glucagon (MSI1, 50.1%; MSI2, 81.8%). At 12 weeks, the
percentage of insulin-positive cells with MSI1 or MSI2 was
67.3% and 79.3%, respectively, whereas the percentage of
glucagon-positive cells with MSI1 or MSI2 was 72.2% and
95.9%, respectively (Figures 2a–d). As a positive control, we
observed both Musashi proteins in human fetal intestine
(Figures 2e and f). Notably, although many of the cells were
Musashi-positive, staining for both Musashi proteins was
stronger in glucagon-positive or insulin/glucagon double-
positive cells compared to cells positive only for insulin
(Figures 2a-d). Recent analysis of human fetal pancreas and
hESC differentiation has demonstrated that insulin/glucagon
double-positive cells are common and may be the
progenitors of mature a-cells.
21,22
We next sought to determine if Musashi expression
changed during hESC differentiation towards the pancreatic
lineage. The mRNA expression levels of both MSI1 and MSI2
increased signiﬁcantly during the course of hESC differentia-
tion from undifferentiated cells to deﬁnitive endoderm and
subsequently to PDX1-positive developing pancreatic pro-
genitor cells (Figures 3a and b). These changes in Musashi
expression were consistent between two different hESC lines
(Figure 3a). MSI1 and MSI2 mRNA levels in adult human
islets were similar to hESC-derived cultures on days 11 and
14, whereas PDX1 mRNA levels were signiﬁcantly higher in
adult human islets compared with all stages of hESC
differentiation (Figure 3b). Both Musashi proteins were also
present in differentiated hESC (day 28), a stage where
pancreatic and endocrine progenitors, immature endocrine
cells and mature endocrine cells are all present, and
colocalizing with a subset of insulin-positive cells (MSI1,
61.4%; MSI2, 67.9%) and glucagon-positive cells (MSI1,
45.6%; MSI2, 68.9%) (Figure 3c). Collectively, these data
suggest a role for Musashi proteins in the fetal pancreas and
directed progenitor cell differentiation, but cast doubt that they
represent true stem cell factors in this system.
Increased Musashi expression with decreased b-cell
differentiation status. We have previously shown that
single adult b-cells from humans, mice and b-cell lines exist
in at least two maturation states, characterized by the onset
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Cell Death and Diseaseof insulin 1 promoter activity.
1,3 Our recently published
microarray analysis of Pdx1
þ/Ins
low immature and Pdx1
þ/
Ins
þ mature human b-cells pointed to an enrichment of
Musashi in immature b-cells.
3 We have also shown that
activin A can dedifferentiate adult b-cells in culture.
2 Here,
we demonstrate that treatment of primary mouse islets and
MIN6 b-cells with activin A signiﬁcantly increased the
expression of Msi1 (Figures 4a and b). Thus, Musashi
genes are present and can be dynamically regulated in
conjunction with the differentiation status of adult islet cells.
ER stress and lipotoxicity regulate Musashi and
Notch pathway gene expression. Type 2 diabetes is
characterized by pancreatic b-cell dedifferentiation and
D
0.0000
0.0004
0.0008
0.02
0.06
0.10 **
*
Glucagon Insulin Musashi 1 Merged Merged/DAPI
Glucagon Insulin Musashi 2 Merged Merged/DAPI
DRAQ5 Glucagon Musashi 1 Insulin Merged
DRAQ5 Glucagon Musashi 2 Insulin Merged
6 12 30 Weeks
Musashi1 Musashi2
?
?
?
?
Actin
Msi1
Age
(weeks) − 6 12 30 6 12 30 12
Islets Exocrine
Mouse Islets
-RT Msi1 Msi2 Msi2
-RT -RT Msi1 Msi1
Human Islets
-RT Msi2
m
R
N
A
Msi1
Msi2
Islets Pituitary
MIN6 CNS
0
10
20
30
40
50
60
70
80
M
u
s
a
s
h
i
 
(
%
 
a
c
t
i
n
)
Islet
*
Islet Islet MIN6
Mouse pancreas
Human pancreas
Figure 1 Expression of Musashi genes in pancreatic islets and b-cells. (a) mRNA expression data were extracted from four independent sources for Musashi-1 (Msi1)
and Musashi-2 (Msi2), as well as other Notch pathway genes for human, mouse and/or rat islets and b-cells . Expression levels for T1DBase (relative expression), FACS-
puriﬁed b-cells and puriﬁed islets microarray (relative expression), MPSS (tpm¼transcripts per million) and Tag-Seq library (tpm¼tags per million) are displayed by color
(see look-up table; nd, data not determined). (b) RT-PCR analysis of human Msi1 (using two different primer sets spanning different exons) and Msi2 in human islets
(representative of 43 experiments). (c) RT-PCR analysis of Msi1 and Msi2 (using two different primer sets spanning different exons) in mouse islets. (d) RT-qPCR
expression analysis of Msi1 and Msi2 in mouse islets (n¼4) and pituitary gland (n¼3). Glucagon and insulin staining in adult human pancreas along with Msi1 (e) and
Msi2 (f). Scale bar¼100mm. Glucagon and insulin staining in adult mouse pancreas along with Msi1 (g) and Msi2 (h). Scale bar¼20mm. (i) Deconvolution microscopy
of Msi1 and Msi2 subcellular location in MIN6 cells. Scale bar¼5mm. Similar results were observed with overexpression of Msi1 and Msi2 ﬂuorescent fusion proteins.
(j)WesternblotforMsi1proteininMIN6cells,isletsandexocrinetissuefrommiceaged6,12 and30weeks(n¼3).Mousebraintissuewasusedasapositivecontrol.*Po0.05
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23–25 Interestingly, our gene expression analysis
showed that HES1 expression was signiﬁcantly increased in
type 2 diabetic islets compared to non-diabetic controls
(Figure 5a). Obesity and free fatty acids increase the risk of
type 2 diabetes, in part by inducing b-cell dedifferentiation,
dysfunction and apoptosis.
26,27 Thus, we investigated
whether hyperglycemia or hyperlipidemia might alter the
expression of Musashi genes. Musashi gene expression was
unaffected by varying the glucose concentration (Figure 5b).
In contrast, lipotoxic conditions induced by the free fatty acid
palmitate signiﬁcantly increased Msi2 (Figure 5c). Consistent
with the increase in Musashi, palmitate induced Hes1 1.8-fold
(Figure 5c). Many of the deleterious effects of palmitate on
b-cell function and survival are mediated by ER stress.
Blocking ER Ca
2þ inﬂux with thapsigargin
28 was sufﬁcient
to induce a signiﬁcant upregulation of Msi1, Msi2 and Hes1
mRNA levels (Figures 5d–f and k). Msi2 protein levels
were also signiﬁcantly increased with thapsigargin treatment
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Figure 2 Expression of MSI1 and MSI2 during human fetal development. (a–d) Glucagon and insulin staining in 8- and 12-week human fetal pancreatic sections along
with MSI1 (a and c) and MSI2 (b and d) staining. Scale bar¼100 and 20mm for merged and expanded images, respectively. (e) MSI1 and (f) MSI2 staining in 12-week
human fetal intestine sections. Scale bar¼200mm
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Cell Death and Disease(Figures 5g and h). As expected, both insulin genes were
highly downregulated with thapsigargin-induced ER stress
(Figures 5d, m and n). Thapsigargin had opposing effects
on Notch1 and Notch2 (Figures 5i and j). Surprisingly, the
g-secretase inhibitor DAPT did not prevent these effects
of thapsigargin, suggesting that the regulation of Ins1, Ins2,
Hes1 and Ngn3 by ER stress is independent of classical Notch
signaling under these experimental conditions (Figures 5e, f
and i–n). In keeping with a Notch-independent mechanism,
we did not see changes in the protein levels of Numb
(Figure 5o), a Notch inhibitor and putative target of Musashi
translational regulation. Taken together, these data demon-
strate that lipotoxicity and ER stress upregulate Musashi and
Hes1 via a non-canonical pathway and suggest a modulatory
role for this pathway in type 2 diabetes. Interestingly, we
did not observe changes in Msi1 or Msi2 expression with
a cocktail of pro-inﬂammatory cytokines designed to mimic
conditions in type 1 diabetes (Figures 5p and q), indicating
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Cell Death and Diseasethat the role of Musashi is relatively speciﬁc to dedifferentia-
tion associated with lipotoxic/ER stress conditions in type 2
diabetes.
Musashi 1 regulates b-cell proliferation and insulin gene
transcription. Thus far, our studies showed that Musashi
levels were associated with changes in b-cell differentiation
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Cell Death and Diseasestatus, but they did not inform us as to whether either of the
Musashi isoforms could drive some or all aspects of this
process. To address the function of Musashi, we used
overexpression and knockdown in MIN6 cells. Transfection
of human MSI1:GFP resulted in signiﬁcant Musashi-1
overexpression, with no change in Msi2 (Figure 6a). Given
the induction of Msi1 under stress conditions and its known
antiapoptotic roles in other cell types,
29 we ﬁrst assessed the
effect of MSI:GFP overexpression on basal and induced
b-cell apoptosis. Indeed, overexpression of MSI1 strongly
reduced basal apoptosis and programmed cell death induced
by proinﬂammatory cytokines and thapsigargin (Figures 5r
and s). Remarkably, overexpression of MSI1 alone was
sufﬁcient to signiﬁcantly decrease Ins2 gene expression
(Figure 6b). On the other hand, shRNA-mediated Msi1
knockdown had only a slight effect on Ins2 (Figures 6f and g),
suggesting that this Musashi isoform is not a necessary
regulator of basal insulin transcription. Taken together,
these data demonstrated that Musashi can drive changes
in b-cell insulin gene expression. We have previously
shown that immature and dedifferentiated states are
associated with increased b-cell proliferation.
1,2 MSI1
overexpression signiﬁcantly increased MIN6 cell prolifera-
tion (Figures 6c and d), while Msi1 knockdown had a
negative effect on proliferation (Figures 6h and i). This
result is consistent with the role of Msi1 in promoting
proliferation of intestinal progenitors.
30 As expected, MSI1
overexpression signiﬁcantly increased Hes1 expression
(Figure 6e) and Msi1 knockdown signiﬁcantly decreased
Hes1 gene expression (Figure 6j), suggesting that Musashi
regulates Hes1 in adult b-cells, similar to other systems.
Although Msi1 and Msi2 are homologs, the differences
in their expression levels suggested the possibility of
non-overlapping functions. MSI2 overexpression signiﬁcantly
decreased Ins1 and Ins2 gene expression (Figures 7a and b),
whereas Msi2 knockdown signiﬁcantly increased Ins2 ex-
pression (Figures 7f and g), similar to the ﬁndings with Msi1.
However, in contrast to the effects of MSI1, MSI2 over-
expression blocked MIN6 proliferation (Figures 7c and d),
whereas Msi2 knockdown augmented MIN6 proliferation
(Figures 7h and i). This was associated with and perhaps
caused by a compensatory effect on Msi1 expression with
MSI2 overexpression or knockdown (Figures 7a and f).
Unexpectedly, both MSI2 overexpression and Msi2 knock-
down increased Hes1 gene expression (Figures 7e and j).
This suggests that Hes1 expression is uncoupled from the
proliferative effects of Musashi and may be regulated
exclusively by Msi1. Taken together, these data suggest that
the Msi1 and Msi2 play overlapping, but distinct, roles in the
control of b-cell proliferation and insulin gene expression and
may also regulate the expression of each other under some
conditions.
Discussion
The purpose of this study was to characterize the presence
and function of the Musashi genes in pancreatic b-cells. We
showed that both isoforms of Musashi were abundant in adult
pancreatic a- and b-cells. Both proteins were also present in
humanfetalpancreasandduringthedirecteddifferentiationof
hESCs towards the pancreatic lineage, but the expression
pattern was not consistent with that of a stem cell marker.
Musashi expression was also elevated with a decreased
differentiation status in adult b-cells and conditions of ER
stress. Musashi overexpression and knockdown experiments
pointedtoa suppressive roleininsulingene expression. Msi1,
but not Msi2, exhibited a proliferative effect. We identify a role
for the known Notch target Hes1, but surprisingly ﬁnd that its
induction is independent of Numb protein levels or Notch
activation (Figure 8).
The Notch/Hes1/Ngn3 pathway plays important roles in the
development of pancreatic endocrine cells. During pancreatic
development, temporally regulated Ngn3 expression is
required for the differentiation of all endocrine lineages.
6,31
Ngn3 is regulated by Notch signaling through repression by
the Notch target gene Hes1.
7 Hence, the Notch/Ngn3
signaling pathway sustains the proliferating pool of pancreatic
progenitor cells and their eventual exocrine or endocrine cell
fates.
8 It has become increasingly evident that the devel-
opmentally critical Notch/Ngn3 signaling pathway is also
active in adult islets, but the upstream regulators of this
pathway in adult islets remain unclear. Ngn3 has been shown
to be expressed, albeit at very low levels, in adult islets at the
mRNA and protein levels.
9,10 We have previously also shown
that inhibiting Notch signaling in adult b-cells increased Ngn3
expression and b-cell apoptosis in a context-dependent
manner, while NGN3 overexpression was sufﬁcient to induce
b-cell apoptosis.
9 This ﬁts with our current data showing
antiapoptotic roles for Musashi, a negative regulator of Ngn3.
Others later showed using conditional gene knockout that
Ngn3 plays a role in adult b-cell maturation and function.
10 In
thisstudy,wehavefurtherconﬁrmedthatseveralcomponents
of the Notch signaling pathway are expressed and active in
adult b-cells, although the signaling between Musashi and
Hes1 does not appear to follow the classical Notch pathway.
Regardless of this atypical mechanism, our data suggest that
Musashi, and perhaps Hes1, contribute to the modulation of
b-cell proliferation and maturation. Our overexpression and
Figure 5 Lipotoxicity and ER stress induce changes in Musashi and the Notch pathway. (a) RT-qPCR analysis of MSI1, MSI2 and HES1 gene expression levels in non-
diabetic (n¼8) and type 2 diabetic human islets (n¼3). (b) MIN6 cells were treated with increasing glucose concentrations for 24h, followed by RT-qPCR analysis of Msi1
and Msi2 mRNA levels (n¼3). (c) MIN6 cells were treated with 1.5mM of the free fatty acid palmitate for 5, 9 or 24h to induce a lipotoxic stress after which Msi1, Msi2 and
Hes1 mRNA levels were quantiﬁed by RT-qPCR. Expression is normalized to untreated control samples (n¼4). (d) MIN6 cells were treated with 1mM thapsigargin for 5, 9
or 24h, followed by RT-qPCR for Msi1, Msi2, Ins1, Ins2 and Hes1.( e–q) MIN6 cells were treated with 5mM DAPT, 1mM thapsigargin or both for 24h (n¼4), followed by
RT-qPCRanalysisofMsi1,Msi2Hes1,Ngn3,Notch1,Notch2,Ins1andIns2mRNAlevels(e,fandi–n)andimmunoblotforMsi1,Msi2andNumb(g,hando).(pandq)MIN6
cells were treated with a cytokine cocktail containingTNF-a (25ng/ml), IL-1b (10ng/ml) and IFN-g (10ng/ml) for 8h (n¼4). (r and s) Overexpression of MSI1:eGFP protects
MIN6 cells from cytokine- and thapsigargin-induced apoptotic cell death. Propidium iodide (PI) incorporation was used as an index of cell death (r), while AnnexinV positivity
was used as an index of caspase-3-dependent apoptosis. Controls are overexpressing an eGFP vector. * Po0.05 versus untreated
#Po0.05 versus eGFP controls
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Cell Death and Diseaseknockdown data also demonstrate that each of the Musashi
genes have generally reciprocal effects on proliferation and
Hes1 gene expression, suggesting that they may have some
distinct functional roles. Our overexpression data also
suggest that Msi2 negatively regulates Msi1.
14 Collectively,
our studies point to a stronger role for Msi1 in regulating
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Cell Death and Diseaseproliferation, modulating b-cell survival and activating Hes1
expression, whereas both Musashi genes seem to regulate
insulin gene expression in the same manner.
We have previously described an immature subpopulation
of adult b-cells in humans and mice marked by Pdx1 promoter
activity with little or no insulin-1 promoter activity.
1–3 MSI2
was signiﬁcantly increased in puriﬁed immature human
b-cells.
3 Here, a subset of adult islets and b-cells strongly
expressed the Musashi genes. The dedifferentiation and
hyperproliferation of adult b-cells by activin A was associated
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Cell Death and Diseasewith an increase in Msi1. Furthermore, our results support the
notion that islets from type 2 diabetes patients have a
dedifferentiated phenotype
23 with increased HES1. Our
knockdown experiments suggest that Musashi acts as a
constitutive break on insulin expression in mature b-cells,
similar to what we have previously shown with follistatin.
2 The
idea that Musashi may be associated with an immature b-cell
phenotype in adult islets is also consistent with its role in other
systems, including a putative breast stem cell population.
12,32
In the central nervous system, both Musashi isoforms were
described to be highly enriched and play a role in the
maintenance of neural stem cells, becoming downregulated
with differentiation.
14 The intestinal crypt, which contains the
highly proliferative stem cell pool, was also characterized by
the expression of both Msi1 and Hes1.
15 This is consistent
with our ﬁndings that MSI1 overexpression increased the
expression of Hes1 as well as proliferation.
Numerousstudieshavereportedmulti-hormonalcellsinthe
embryonic and fetal pancreas,
33–35but the factors thatgovern
this state are unclear. In human fetal pancreas, we found that
both Musashi isoforms were present in cells that expressed
insulin and glucagon or both. While early studies employing
toxin-mediated lineage reduction suggested that the majority
of adult mouse b-cells had not previously expressed the
glucagonpromoter,
36morerecentdatapointtotheproduction
of b-cells under extreme stress conditions from cells with
transient glucagon promoter activity.
5 Our group has recently
characterized a large population of bihormonal cells in the
human fetal pancreas and provided histological evidence that
they may give rise to mature a-cells.
22 This observation
mirrored the multi-hormonal cells seen after directed hESC
differentiation.
21 Single-cell transcript analysis supports
existence of islet cells co-expressing multiple hormones,
including insulin and glucagon.
37,38 Microarray analysis of
immature versus mature b-cells from humans, mice and MIN6
cells revealed that the immature cells were multi-hormonal.
3
Considering that MSI2 was also signiﬁcantly upregulated in
immature human b-cells, our results support the concept that
elevated Musashi may be found in an immature cell state in
the adult pancreas and perhaps the possibility of expressing
multiple hormones.
We have identiﬁed Musashi as a possible link between ER
stress to the downregulation of insulin expression seen in the
type2diabetesandlipotoxicity.
39GiventhatMusashiappears
to represent a compensatory protective gene, it is possible
that it could transduce the effects of ER stress and lipotoxicity
into an increase in b-cell proliferation and b-cell mass typically
seen in the early stages of type 2 diabetes.
23–25 It is well
established that ER stress is associated with general
translational inhibition, but our study now implicates Musashi,
a translational repressor, in the stress-dependent control of
the insulin gene. Analysis of publically accessible resources
and our own expression studies demonstrated that the
Musashi/Hes1 pathway may be increased in islets from
patients with type 2 diabetes. Although multiple stresses
affect islets in the complex milieu of diabetes, we demon-
strated in vitro that lipotoxicity with the free fatty acid palmitate
is sufﬁcient to recapitulate the increase in Musashi and Hes1
gene expression. Further, we demonstrated that the ER
stresscomponentofpalmitate-inducedlipotoxicityissufﬁcient
for the increase in Musashi levels. However, our data suggest
that ER-stress-induced effects on Hes1 may be Numb- and
Notch-independent. Hence, other Musashi targets likely link
Musashi and Hes1. Taken together with our observations that
increases in Musashi were sufﬁcient to reduce insulin
expression, inhibit apoptosis and increase b-cell proliferation,
these data suggest that Musashi may be involved in the
decreased level of insulin expression and possibly the
subsequent b-cell dedifferentiation seen in type 2 diabetes.
Collectively, our results are the ﬁrst to demonstrate that
Musashi is present in developing and adult b-cells, where it is
responsive to multiple external factors that regulate cellular
differentiation status, including ER stress. Our data point to
differences in the functional roles of Musashi-1 and Musashi-
2, while suggesting a conserved role for this gene family as an
upstream regulator of Hes1. Our gain-of-function and loss-of-
function studies demonstrate that Musashi is necessary and
sufﬁcient to suppress b-cell proliferation and insulin gene
expression. Musashi-1 and Musashi-2 are novel regulators of
b-cell function and fate.
Materials and Methods
Reagents. Respective RFP- and GFP-bearing shRNA constructs targeted to
Msi1 and Msi2 were purchased from OriGene (Rockville, MD, USA).
Overexpression constructs for human MSI1-GFP and GFP control plasmids were
purchased from OriGene. Human MSI2-mCherry and mCherry control plasmids
were purchased from GeneCopoeia (Rockville, MD, USA). These were introduced
to cells by transfection (Lipofectamine 2000; Invitrogen, Burlington, ON, USA) or in
later experiments by the Invitrogen Neon instrument. Recombinant human activin A
waspurchasedfromR&DSystems(Minneapolis,MN,USA).Thapsigarginwasfrom
Sigma (Oakville, ON, USA). Palmitate (Sigma) was made up as a complex to BSA
as describedpreviously.
26 The g-secretase inhibitor of Notch activation, DAPT, was
purchased from Sigma.
Cell culture. All cell culture reagents were from Invitrogen, unless otherwise
stated. Human islets were provided by the Ike Barber Human Islet Transplant
?
?
Musashi 1 Musashi 2
Proliferation Insulin expression Apoptosis
ER-stress
Lipotoxicity
Hes1 Ngn3
Notch/Numb
-independent
signalling
Notch signalling
Dedifferentiation factors
(e.g. activin A)
Downstream mechanisms remain to be formally tested
?
Figure 8 Working model of Musashi regulation and action in adult b-cells. Our
datasuggestthat Musashi-1 andMusashi-2aredifferentiallyregulatedby upstream
signals, and possibly each other that Musashi-1 and Musashi-2 regulate insulin
expression, proliferation and apoptosis, via Notch- and Numb-independent
signaling. This is associated with changes in Hes1 mRNA, suggesting that this
downstream gene may play a role in the mechanism
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Cell Death and DiseaseLaboratory (Vancouver General Hospital, Vancouver, BC, Canada). Mouse islets
wereisolatedfrom 10–12-week-old C57BL/6Jmiceusing collagenaseandﬁltration.
Islets were hand-picked and cultured overnight at 371C and 5% CO2 in RPMI1640
medium supplemented with 5mM glucose (for human islets) and 11mM glucose
(for mouse islets), 100U/ml penicillin, 100mg/ml streptomycin and 10% fetal bovine
serum (Invitrogen). All animal protocols were approved by the University of British
Columbia, in accordance with national guidelines. MIN6 cells were cultured as
described.
1
Pancreatic differentiation of hESCs. HESCs derived from the H1 line
and a variant of the CA1 line, CA1S, were maintained as undifferentiated
populations on 1:30 diluted Matrigel (BD Biosciences, Bedford, MA, USA) in
mTesR1 maintenance medium (Stem Cell Technologies, Vancouver, BC, Canada)
as described elsewhere.
40 Cells were passaged every 3–7 days by passaging 1:3
to 1:6 to maintain culture densities between 30 and 80% conﬂuent. Pancreatic
differentiationofhEScellswascarriedoutfollowingthestage-speciﬁcdifferentiation
methods described previously.
21
Gene expression analysis. Bioinformatic analysis of gene expression was
carried out using our previously described approach.
19 For RT-PCR and qRT-PCR,
total RNA was puriﬁed using the RNeasy kit (Qiagen, Mississauga, ON, Canada).
cDNA was prepared from 200 to 600ng of RNA using the qScript cDNA Synthesis
Kit (Quanta Biosciences, Gaithersburg, MD, USA). Primers were designed to ﬂank
an intron and are available on request. qRT-PCR was performed by using the
PerfeCTa SYBR Green SuperMix with ROX (Quanta Biosciences) and Step One
PlusReal-TimePCRSystem(AppliedBiosystems,Carlsbad,CA,USA).Forrelative
quantiﬁcation of transcripts, Ct values for each sample were normalized to GAPDH
andALDOA for human samples,and HPRT1and b-actin for mouse samples, using
the Data Assist software (Applied Biosystems). RT-PCR was performed using Taq
polymerase (Fermentas, Burlington, ON, Canada).
Immunoblot. MIN6cells,mouse islets,mouse exocrinetissueandmouse brain
tissuewerelysedincelllysisbuffer(CellSignalingTechnology,Danvers,MA,USA).
All other immunoblot methods were performed as described,
19 using primary
antibodiesasfollows:mouseanti-b-actin(1:1000;NovusBiologicals,Littleton,CO,
USA), rabbit anti-Musashi-1 and -2 (1:500; Millipore, Billerica, MA, USA), mouse
anti-Numb/Cnmb-1 (1:200; Developmental Studies Hybridoma Bank, University of
Iowa, Iowa City, IA, USA) and rabbit anti-Notch1 (1:1000; Cell Signaling
Technology).
Online analysis of single b-cell apoptosis. Cell death and apoptosis
were tracked via the nuclear incorporation of propidium iodide (PI; near red; all
forms of cell death) and AlexaFluor647-conjugated AnnexinV (far red; apoptosis)
binding to the outer membrane (and eventually entering the cell). Nuclear
morphology and cell numbers were visualized with a low concentration of Hoechst.
The number of control (eGFP only) and MSI:GFP-overexpressing cells that also
expressed PI and/or AnnexinV were counted automatically using the Molecular
Devices ImageXpress
MICRO high-content screening instruments.
Fluorescence staining. Human islets and pancreata from adult donors
between23and56yearsoldofeithersexwereobtainedfromconsentingdonorsvia
the Clinical Islet Transplantation Program at the Vancouver General Hospital and
were not from diabetic donors, unless otherwise indicated. Human fetal pancreas
sections were kindly provided by Dr. Rennian Wang (University of Western Ontario,
London, ON, Canada). Pancreas sections were 5mm. Isolated mouse pancreata
and human fetal tissues were ﬁxed in 4% paraformaldehyde (PFA) overnight at
41C, rinsedin 70% ethanoland embeddedin parafﬁn.The tissuewas sectioned for
immunostaining at 5mm thickness. Staining of mouse and human adult and fetal
pancreas sections was performed as described previously.
21 MIN6 cells were
seeded at low density on coverslips for single-cell staining before ﬁxing in PFA.
Polyclonal rabbit-anti-Musashi-1 (1:200) and rabbit-anti-Musashi-2 (1:200)
were purchased from Millipore. Polyclonal guinea-pig anti-insulin (1:1000) was
from Millipore. Mouse anti-glucagon (1:1000) was from Sigma (St. Louis, MO,
USA). Images were taken on the ImageXpress
MICRO using high NA objectives and
analyzed using the MetaXpress software (Molecular Devices Corporation,
Sunnyvale, CA, USA).
5-Bromo-2-deoxyuridine (BrdU) labeling was performed on MIN6 cells
overexpressing Musashi fusion proteins or ﬂuorescent protein-bearing shRNA
constructs puriﬁed by FACS. BrdU (10mM; Kit I; Roche, Laval, QC, Canada) was
added to FACS-puriﬁed MIN6 cells for 3–6h before ﬁxation. Cells were imaged
using a Zeiss 200 M microscope equipped with a FLUAR  10 and  100 (1.45
NA) objectives (Carl Zeiss, Thornwood, NY, USA) and ImageXpress
MICRO. Images
were analyzed and deconvolved using SlideBook (Intelligent Imaging Innovations,
Boulder,CO,USA)orAcuityXpress(MolecularDevicesCorporation).Aminimumof
500 cells per sample were quantiﬁed.
Data analysis. Data are presented as means±S.E.M. Differences between
means were evaluated by Student’s unpaired t-tests or one-way ANOVA, as
appropriate. A P-value of 0.05 or less was considered signiﬁcant. A minimum of
three independent experiments were performed for each study.
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